Earth Science Tech, Inc. (OTC: ETST) reported financial results for the fiscal year ended March 31, 2026, showing revenue growth and higher earnings. The company achieved revenue of $35.7 million, an 8% increase from the prior year, driven by expansion of its integrated healthcare platform. Gross profit rose 5% to $25.5 million, and net income increased 11% to $3.6 million compared with fiscal 2025. Total assets grew 27% year over year to $9.0 million, reflecting the company's continued investment in telemedicine, pharmacy, and fulfillment services.
Management highlighted the company's capital allocation strategy, noting that it repurchased and retired more than 4 million shares during fiscal 2026 and more than 7.1 million shares through fiscal 2026 and subsequent periods. The company generated positive operating cash flow and strengthened its balance sheet without incurring additional debt. As it enters fiscal 2027, Earth Science Tech remains focused on growth initiatives, product expansion, and continued share repurchases.
The company's integrated healthcare platform combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. This vertical integration allows for seamless patient care from consultation to fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business.
For more details, the full press release is available at https://ibn.fm/NpjTw. Investors can find the latest news and updates on ETST in the company's newsroom at https://ibn.fm/ETST.
